


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+22.23%
+10.11%
+2.46%
UNH
UnitedHealth Group Incorp
$324.54
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Risk Analysis

Investors losing their confidence
UNH Price Performance
$341.56 (-4.98%)
$310.38 (+4.56%)
$302.91 (+7.14%)
$533.53 (-39.17%)
UNH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

UNH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue increase YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
UNH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
UNH Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is UNH current stock price?
What are UNH stock strengths?
What is UNH Risk Level?
What is UNH market cap and volume?
What is UNH current Stock IQ?
Should I buy UNH stock right now?
Is UNH a Strong Buy right now?
What does a 'Strong Buy' rating mean for UNH?
What does a 'Strong Sell' rating mean for UNH?
What factors influence UNH's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+22.23%
+10.11%
+2.46%
UNH
UnitedHealth Group Incorp
Current Price
$324.54
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Risk Analysis

Investors losing their confidence

UNH Price Performance
$341.56 (-4.98%)
$310.38 (+4.56%)
$302.91 (+7.14%)
$533.53 (-39.17%)
UNH Analysts Opinion
UNH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Revenue increase YoY

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
UNH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
UNH Street Sentiment is bullish and have positive views on the near-term outlook
UNH has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
UNH Stock IQ
UNH Latest Analysis
Is UnitedHealth an Undervalued Stock to Buy Now?.
Tue Dec 2, 2025
Wells Fargo Analyst has a Positive Outlook on UnitedHealth Group (UNH). UnitedHealth Group Incorporated (NYSE:UNH) is one of the best dividend stocks to buy according to hedge funds. On November 12 Wells Fargo analyst Stephen Baxter assigned a Buy rating on UnitedHealth while setting the price target at $400. A separate November 25 report suggests that UnitedHealthcare and TriHealth discussions are still ongoing as a compensation [….]
Tue Dec 2, 2025
UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale. UNH) has reportedly reached a $1 billion agreement to sell its remaining South American operation Banmedica to Brazilian private equity firm The move reflects the company'.s broader push to streamline operations and support its under CEO Citing people familiar with the negotiations Reuters noted that the deal was signed on Saturday. A formal announcement is expected on Monday.UnitedHealth began unwinding its Latin A
Mon Dec 1, 2025
UnitedHealth: Uncertainties Loom (Downgrade).
Mon Dec 1, 2025
Should You Buy Shares of UnitedHealth in November?. Key PointsUnitedHealth stock has tumbled 35% this year amid a series of headwinds.
Mon Nov 24, 2025
UnitedHealth: Buy Before The Buybacks Resume.
Thu Nov 20, 2025
$100 Invested In UnitedHealth Group 15 Years Ago Would Be Worth This Much Today. UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 15 years by 3.2% on an annualized basis producing an average annual return of 15.37%. Currently UnitedHealth Group has a market capitalization of $277.46 billion.
Wed Nov 19, 2025
Is UnitedHealth Group (UNH) Trading at an Attractive Valuation?.
Wed Nov 19, 2025
UnitedHealth names former US FDA chief Scott Gottlieb to its board.
Tue Nov 18, 2025
UnitedHealth Groups Options: A Look at What the Big Money is Thinking. Deep-pocketed investors have adopted a bearish approach towards UnitedHealth Group (NYSE:UNH) and it'.s something market players shouldn'.t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown but such a substantial move in UNH usually suggests something big is about to happen.We gleaned this information from our observations t
Mon Nov 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.